Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219745 · ClinicalTrials.gov registry record · NA
Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS)
A NA study, sponsored by Case Comprehensive Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07219745 is a NA study that has not yet begun recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 60 participants.
The verdict
NCT07219745, a NA study, has not yet begun recruiting, sponsored by Case Comprehensive Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Transanal irrigation (TAI) has shown to improve fecal incontinence and increase quality of life in patients with low anterior resection syndrome (LARS). This trial is a small study being conducted to determine whether a larger trial is feasible. Investigators are also doing this research to see if TAI impacts quality of life and improves bowel function within the early post-operative period (1-12 months). This treatment is designed for participants to have more control over their bowel movements and reduce the dependency on immediate access to the toilet.
Interventions
- DEVICE Peristeen Plus Irrigation kit
- OTHER LARS mobile application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-10 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07219745
The ClinicalTrials.gov registry entry for NCT07219745 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peristeen Plus Irrigation kit is the first listed.
NCT07219745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07219745 about?
NCT07219745 is a clinical study titled "Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS)". Transanal irrigation (TAI) has shown to improve fecal incontinence and increase quality of life in patients with low anterior resection syndrome (LARS). This trial is a small study being conducted to determine whether a larger trial is feasible. Investigators are also doing this research to see if T...
What is the current status of trial NCT07219745?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-10. Estimated completion is 2027-11.
What interventions are being tested in trial NCT07219745?
The interventions under investigation include: Peristeen Plus Irrigation kit (DEVICE), LARS mobile application (OTHER).
Who is sponsoring clinical trial NCT07219745?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.